Sodium Fluoride F 18 (Global Isotopes, LLC d/b/a Zevacor Molecular)


Welcome to the PulseAid listing for the Sodium Fluoride F 18 drug offered from Global Isotopes, LLC d/b/a Zevacor Molecular. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Global Isotopes, LLC d/b/a Zevacor Molecular
NON-PROPRIETARY NAME: Sodium Fluoride F 18
SUBSTANCE NAME: FLUORIDE ION F-18
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-10-31
END MARKETING DATE: 0000-00-00


Sodium Fluoride F 18 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Fluoride F 18 from Global Isotopes, LLC d/b/a Zevacor Molecular
LABELER NAME: Global Isotopes, LLC d/b/a Zevacor Molecular
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mCi/mL)
START MARKETING DATE: 2014-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69126-002_42f45bd6-bee2-4073-b838-7d7561cf4393
PRODUCT NDC: 69126-002
APPLICATION NUMBER: ANDA204464

Other FLUORIDE ION F-18 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Global Isotopes, LLC d/b/a Zevacor MolecularSodium Fluoride F 18